• Stock Chart

    Stock Chart

    Cannabics Pharmaceuticals, Inc.(CNBX)

    US OTC

    $0.2435

    0.006(2.526%)

    CNBX Company Profile

    No. 3 Bethesda Metro Center

    Bethesda, MD 20814
    1.877.424.2429
    http://www.cannabics.com
    Sector: Health Technology
    Industry: Biotechnology
    Full Time Employees: 5

    Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

    • Previous Close
      0.2375
    • Open
      0.22
    • Bid
    • Ask
    • Day's Range
      0.22 - 0.2495
    • 52 week Range
      0.066 - 0.61
    • Volume
      107742
    • Avg. Volume
      189780
    • Market Cap
      32881023
    • Beta (5Y Monthly)
      0.22
    • PE Ratio (TTM)
      -4.11
    • EPS (TTM)
    • Earnings Date
      0.22
    • Forward Dividend & Yield
      0.22
    • Ex-Dividend Date
      107742
    • 1y Target Est
      0.22

    KEEP ME INFORMED ON CNBX UPDATES

    CNBX Performance

    • 5 Day
      16.0076%
    • 1 Month
      -8.8015%
    • 3 Month
      57.0968%
    • YTD
      111.3715%
    • 1 Year
      -13.8053%

    CNBX on iHub

    CNBX News

    /*
  • */